Skip to Content
Merck
CN

P4153

Prednisolone 21-hemisuccinate sodium salt

≥90%, powder

Synonym(s):

Δ1-Hydrocortisone 21-hemisuccinate, 1,4-Pregnadiene-11β,17,21-triol-3,20-dione 21-hemisuccinate, 11β,17α,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
C25H31O8Na
CAS Number:
Molecular Weight:
482.50
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
51111800
EC Number:
216-995-1
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

HLHQSPQPHMOTMP-FKIWUUNWSA-N

InChI

1S/C25H32O8.Na.H/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;;/h7,9,11,16-18,22,27,32H,3-6,8,10,12-13H2,1-2H3,(H,29,30);;/t16-,17-,18-,22+,23-,24-,25-;;/m0../s1

SMILES string

[Na].[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]4(C)[C@@]2([H])CC[C@]4(O)C(=O)COC(=O)CCC(O)=O

biological source

synthetic

sterility

non-sterile

assay

≥90%

form

powder

shipped in

ambient

storage temp.

−20°C

Quality Level

color

, White to Light Yellow to Light Beige

solubility

hot water: 50 mg/mL, clear to very slightly hazy (Colorless to Light Yellow to Light Brown-Yellow)

pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Repr. 1B

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mareike Probst et al.
International journal of pharmaceutics, 532(1), 519-527 (2017-09-25)
The number of intramuscularly applied dosage forms has been continuously increasing during the last decades. However, up to date no in vitro dissolution test method for parenteral dosage forms has been described in the Ph. Eur. or USP. It was
Hiraku Onishi et al.
International journal of pharmaceutics, 410(1-2), 17-22 (2011-03-15)
Recently, many people have developed rheumatoid arthritis (RA), and prednisolone (PD) is often used for treatment; however, long use and a large dose of PD can cause toxic side effects. In this study, in order to enhance the therapeutic effects
Toru Ohashi et al.
Acta oto-laryngologica, 132(2), 133-140 (2011-12-29)
Abnormal action potential (AP) recovery from adaptation was manifested as increased recovery (iR) or decreased recovery (dR) relative to the normal recovery range. dR was not analyzed statistically due to the very small number of cases. iR is considered an
Ellen C La Heij et al.
American journal of ophthalmology, 143(1), 176-178 (2006-12-26)
To evaluate the six-month results of patients treated with intravitreal prednisolone sodium succinate injections for persistent diabetic macular edema. Retrospective, noncontrolled, clinical case series. Nineteen eyes had intravitreal injections with prednisolone sodium succinate. Need for retreatment was based on fluorescein
Tomofumi Ogoshi et al.
Modern rheumatology, 18(6), 552-561 (2008-07-24)
The influence of glucocorticoid (GC) on bone in rats at different ages was investigated in order to provide insight into human glucocorticoid induced osteoporosis (GCOP). Three-, 6-, and 12-month-old female Wistar rats were divided into four groups: Zero-time control (ZT)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service